Bellerophon Therapeutics, Inc. (BLPH:NASDAQ) soared at $18, representing a gain of 431%. On Thu 19 Mar 20, BLPH:NASDAQ touched a New 2-Week Low of $3.39. The stock appeared on our News Catalysts scanner on Fri 20 Mar 20 at 12:41 PM in the 'BIOTECH' category. From Thu 05 Mar 20, the stock recorded 20.00% Up Days and 27.27% Green Days
The stock spiked on Tue 18 Feb 20 at $11.98 with a volume of 23M+.
About Bellerophon Therapeutics, Inc. (BLPH:NASDAQ)
Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.
Top 10 Gainers:
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 430.97%
- Frontier Communications Corporation (FTR:NASDAQ), 278.95%
- Fiesta Restaurant Group, Inc. (FRGI:NASDAQ), 214.9%
- Satsuma Pharmaceuticals, Inc. (STSA:NASDAQ), 112.64%
- Mammoth Energy Services, Inc. (TUSK:NASDAQ), 78.46%
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 71.65%
- Consumer Portfolio Services, Inc. (CPSS:NASDAQ), 69.09%
- Aemetis, Inc. (AMTX:NASDAQ), 69.05%
- Town Sports International Holdings, Inc. (CLUB:NASDAQ), 69.04%
- Unit Corporation (UNT:NYSE), 63.88%